Banfi P, Lanzi C, Falvella F S, Gariboldi M, Gambetta R A, Dragani T A
Division of Experimental Oncology B, Istituto Nazionale Tumori, Milano, Italy.
Mol Pharmacol. 1994 Nov;46(5):896-900.
A rabbit antiserum developed against purified rat liver daunorubicin-binding protein of M(r) 54,000 (DNR-BP54) cross-reacted with a mouse protein of the same molecular weight. This protein was expressed in the liver and several other organs of mice. A series of tumors and cell lines tested for the presence of the protein were negative. By immunocytochemistry, we found that DNR-BP54 was abundantly expressed in the cytoplasm of normal hepatocytes but was expressed at much lower levels in urethane-induced mouse liver tumors. By immunoscreening of a mouse liver cDNA library, we cloned the cDNA coding for DNR-BP54 and we found that this protein is aldehyde dehydrogenase-2 (EC 1.2.1.3). This result was confirmed by the dehydrogenase activity found in pure preparations of DNR-BP54 from normal rat and mouse livers, assayed with acetaldehyde as substrate and NAD as cofactor. The enzyme activity was inhibited by daunorubicin. The inhibition was found to be competitive with respect to NAD.
一种针对纯化的分子量为54,000的大鼠肝脏柔红霉素结合蛋白(DNR - BP54)制备的兔抗血清,与一种分子量相同的小鼠蛋白发生交叉反应。这种蛋白在小鼠的肝脏和其他几个器官中表达。检测的一系列肿瘤和细胞系均未发现该蛋白。通过免疫细胞化学方法,我们发现DNR - BP54在正常肝细胞的细胞质中大量表达,但在氨基甲酸乙酯诱导的小鼠肝脏肿瘤中表达水平低得多。通过对小鼠肝脏cDNA文库进行免疫筛选,我们克隆了编码DNR - BP54的cDNA,并且发现该蛋白是醛脱氢酶 - 2(EC 1.2.1.3)。以乙醛为底物、NAD为辅因子,对来自正常大鼠和小鼠肝脏的DNR - BP54纯品制剂进行脱氢酶活性测定,证实了这一结果。柔红霉素可抑制该酶活性。发现这种抑制作用对NAD而言是竞争性的。